Full Name *

Email *

Phone *

This submission is protected and HIPAA compliant. ADVARRA IRB APPROVED | Cancer DNA/RNA Exploratory Biospecimen Collection Study | Protocol: Cancer Cell Diagnostics, Inc. 2026.08v1 | Advarra Protocol No.: PRO04075939 | IRB Approval Date: August 26, 2026 | IRB Approval Expiration: August 26, 2027

Are you 21 years or older? *

Yes

Address

Street Address

Country

State

City

Postal Code

Do you have a Pathology report that includes molecular testing? *

Yes

If you are comfortable sharing, upload a copy of your pathology report. *

Click to upload

I authorize the CCDx Study Team to review the documents I share and upload to determine study eligibility. *

Yes